Your browser doesn't support javascript.
loading
Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.
Visioli, Alberto; Trivieri, Nadia; Mencarelli, Gandino; Giani, Fabrizio; Copetti, Massimiliano; Palumbo, Orazio; Pracella, Riccardo; Cariglia, Maria Grazia; Barile, Chiara; Mischitelli, Luigi; Soriano, Amata Amy; Palumbo, Pietro; Legnani, Federico; DiMeco, Francesco; Gorgoglione, Leonardo; Pesole, Graziano; Vescovi, Angelo L; Binda, Elena.
Afiliación
  • Visioli A; StemGen SpA, Milan, Italy.
  • Trivieri N; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Mencarelli G; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Giani F; StemGen SpA, Milan, Italy.
  • Copetti M; Biostatistical Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Palumbo O; Medical Genetics Unit, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
  • Pracella R; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Cariglia MG; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Barile C; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Mischitelli L; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Soriano AA; Cancer Stem Cells Unit, Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapeutics (ISBReMIT), IRCSS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo, FG, Italy.
  • Palumbo P; Medical Genetics Unit, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
  • Legnani F; Department of Neurosurgery, National Neurologic Institute IRCCS C. Besta, Milan, Italy.
  • DiMeco F; Department of Neurosurgery, National Neurologic Institute IRCCS C. Besta, Milan, Italy.
  • Gorgoglione L; Department of Neurosurgery, John Hopkins University, Baltimore, Mariland, USA.
  • Pesole G; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Vescovi AL; Neurosurgery Unit, IRCCS Casa Sollievo della Sofferenza, Milan, Italy.
  • Binda E; Department of Biosciences, Biotechnology and Environment, University of Bari A. Moro, Bari, Italy.
J Exp Clin Cancer Res ; 42(1): 244, 2023 Sep 21.
Article en En | MEDLINE | ID: mdl-37735434

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Glioma Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Glioma Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido